acta diurna · run record
2026-10-29-medtech
29 October 2026 ·published
| # | stage | model | verdict | retries | notes | cost |
|---|---|---|---|---|---|---|
| 01 | nuncio | deepseek/deepseek-v4-flash | — | — | rss:FierceBiotech failed (Cannot convert object to primitive value) [optional] | rss:Fierce Pharma failed (Cannot convert object to primitive value) [optional] | 3 gathered stories already covered by the Specola — excluded: "STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies", "STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology", "STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down" | $0.0003 |
| 02 | bulletins | anthropic/claude-sonnet-5 | — | — | "Is AI more a partner, competitor, or crutch for biomedical scientists?": pass (0 redispatch) | "Why every health care AI company must face Epic": pass (0 redispatch) | "Beijing-based BioGeometry gets $100M+ for AI drug R&D": pass (0 redispatch) | "Biopharma industry at odds over impact of Treasury’s new China rule": pass (0 redispatch) | $0.0268 |
| 03 | dispatch | anthropic/claude-sonnet-5 | pass | — | $0.0692 | |
| 04 | rounds | anthropic/claude-sonnet-5 | pass | — | $0.0426 | |
| 05 | illuminate-rounds | — | — | — | skipped: no FAL_KEY — "The Toll-Road That Became the Sky" publishes without a plate | $0.0000 |
| the day's wage | $0.1388 | |||||